Edition:
India

Sumitomo Dainippon Pharma Co Ltd (4506.T)

4506.T on Tokyo Stock Exchange

1,222JPY
30 Oct 2020
Change (% chg)

¥-46 (-3.63%)
Prev Close
¥1,268
Open
¥1,265
Day's High
¥1,267
Day's Low
¥1,217
Volume
1,187,200
Avg. Vol
852,026
52-wk High
¥2,219
52-wk Low
¥1,166

Latest Key Developments (Source: Significant Developments)

FDA Grants Spirovant Sciences Orphan Drug & Rare Pediatric Disease Status For SPIRO-2101 For Cystic Fibrosis Treatment
Thursday, 24 Sep 2020 

Sept 24 (Reuters) - Spirovant Sciences::SPIROVANT SCIENCES - FDA GRANTS CO ORPHAN DRUG AND RARE PEDIATRIC DISEASE DESIGNATIONS FOR SPIRO-2101 FOR TREATMENT OF CYSTIC FIBROSIS.  Full Article

Cynata Therapeutics Receives Indicative Non-Binding Proposal From Sumitomo Dainippon Pharma
Friday, 19 Jul 2019 

July 19 (Reuters) - Cynata Therapeutics Ltd ::CONFIRMS RECEIPT OF INDICATIVE NON-BINDING PROPOSAL.DECIDED TO GRANT NON-EXCLUSIVE DUE DILIGENCE ACCESS TO SUMITOMO.DEAL FOR A$2.00 PER SHARE IN CASH.RECEIVED AN INDICATIVE, NON-BINDING AND CONDITIONAL PROPOSAL FROM SUMITOMO DAINIPPON PHARMA.CYNATA'S DISCUSSIONS WITH OTHER PARTIES HAVE CEASED.  Full Article

BRIEF-Sumitomo Dainippon Pharma Oncology Announces Its Formation Through Merger Of Tolero And Boston Biomedical

* SUMITOMO DAINIPPON PHARMA ONCOLOGY ANNOUNCES ITS FORMATION THROUGH MERGER OF TOLERO AND BOSTON BIOMEDICAL Source text for Eikon: Further company coverage: